• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C9在补体介导的奈瑟菌杀伤中的作用。

The role of C9 in complement-mediated killing of Neisseria.

作者信息

Harriman G R, Esser A F, Podack E R, Wunderlich A C, Braude A I, Lint T F, Curd J G

出版信息

J Immunol. 1981 Dec;127(6):2386-90.

PMID:6795273
Abstract

During the routine examination of a healthy 31-yr-old woman, we found an incomplete deficiency of the 9th component of complement (C9). By hemolytic assay her serum C9 activity was 10 to 15% of normal. Limited family studies suggested that she inherited the deficiency as an autosomal codominant trait. She had no history of unusual or severe infections. When tested for bactericidal activity against serum-sensitive Neisseria gonorrhoeae and N. meningitidis, her serum reacted comparably to normal serum. Normal serum depleted immunochemically of C9 and sera from congenitally C9-deficient patients were also bactericidal against serum-sensitive Neisseria but required 120 min to kill the same numbers of gonococci that intact serum killed within 30 min. In the electron microscope, N. gonorrhoeae incubated with C9-depleted serum were fragmented but lacked the typical C lesions. Therefore, serum lacking C9 can kill serum-sensitive Neisseria, unlike sera deficient in the other terminal C components.

摘要

在对一名31岁健康女性进行常规检查时,我们发现其补体第9成分(C9)存在不完全缺陷。通过溶血试验,她的血清C9活性为正常水平的10%至15%。有限的家系研究表明,她以常染色体共显性性状遗传了这种缺陷。她没有异常或严重感染的病史。在检测针对血清敏感的淋病奈瑟菌和脑膜炎奈瑟菌的杀菌活性时,她的血清反应与正常血清相当。免疫化学去除C9的正常血清以及先天性C9缺陷患者的血清对血清敏感的奈瑟菌也具有杀菌作用,但杀死相同数量的淋球菌需要120分钟,而完整血清在30分钟内即可完成。在电子显微镜下,与去除C9的血清一起孵育的淋病奈瑟菌发生了碎片化,但没有典型的C损伤。因此,与缺乏其他终末补体成分的血清不同,缺乏C9的血清可以杀死血清敏感的奈瑟菌。

相似文献

1
The role of C9 in complement-mediated killing of Neisseria.C9在补体介导的奈瑟菌杀伤中的作用。
J Immunol. 1981 Dec;127(6):2386-90.
2
Inherited deficiency of the ninth component of complement in man.人类补体第九成分的遗传性缺陷。
J Immunol. 1980 Nov;125(5):2252-7.
3
Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.人类补体第八成分缺乏。血清淋病奈瑟菌杀菌活性对C8的需求。
J Clin Invest. 1976 Feb;57(2):283-90. doi: 10.1172/JCI108279.
4
Deficiency of the ninth component of complement in man.人类补体第九成分缺乏症。
J Clin Lab Immunol. 1979 Apr;2(1):85-7.
5
Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.针对淋球菌蛋白I的单克隆抗体在杀菌活性方面存在差异。
J Immunol. 1985 May;134(5):3411-9.
6
Studies on the mechanism of bacterial resistance to complement-mediated killing. IV. C5b-9 forms high molecular weight complexes with bacterial outer membrane constituents on serum-resistant but not on serum-sensitive Neisseria gonorrhoeae.细菌对补体介导杀伤的抗性机制研究。IV. C5b-9与血清抗性淋病奈瑟菌而非血清敏感淋病奈瑟菌的细菌外膜成分形成高分子量复合物。
J Immunol. 1983 Sep;131(3):1443-51.
7
Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli.补充补体成分C9可增强新生儿血清杀灭多种致病性大肠杆菌分离株的能力。
Pediatr Res. 1994 Apr;35(4 Pt 1):389-96.
8
Further studies on C9 deficiency.关于C9缺陷的进一步研究。
J Clin Lab Immunol. 1981 Jul;6(1):7-11.
9
Bactericidal activity of C9-deficient human serum.C9缺陷型人血清的杀菌活性。
J Immunol. 1992 Feb 1;148(3):837-43.
10
The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.大肠杆菌与正常人血清的相互作用:血清介导的脂多糖释放动力学及其与细菌杀伤的解离
J Immunol. 1986 Aug 15;137(4):1329-35.

引用本文的文献

1
Terminal complement complexes with or without C9 potentiate antimicrobial activity against .具有或不具有C9的末端补体复合物增强对……的抗菌活性。
mBio. 2025 May 14;16(5):e0014125. doi: 10.1128/mbio.00141-25. Epub 2025 Mar 31.
2
Terminal complement complexes with or without C9 potentiate antimicrobial activity against .有或没有C9的末端补体复合物增强针对……的抗菌活性。
bioRxiv. 2025 Jan 16:2025.01.16.633325. doi: 10.1101/2025.01.16.633325.
3
Complement terminal pathway inhibition reduces peritoneal injuries in a rat peritonitis model.
补体末端途径抑制减少腹膜炎大鼠模型中的腹膜损伤。
Clin Exp Immunol. 2023 Dec 12;214(2):209-218. doi: 10.1093/cei/uxad088.
4
Efficacy of an Experimental Gonococcal Lipooligosaccharide Mimitope Vaccine Requires Terminal Complement.实验性淋球菌脂寡糖模拟肽疫苗的疗效需要末端补体。
J Infect Dis. 2022 May 16;225(10):1861-1864. doi: 10.1093/infdis/jiab630.
5
Polymerization of C9 enhances bacterial cell envelope damage and killing by membrane attack complex pores.C9 的聚合增强了膜攻击复合物孔对细菌细胞包膜的损伤和杀伤作用。
PLoS Pathog. 2021 Nov 9;17(11):e1010051. doi: 10.1371/journal.ppat.1010051. eCollection 2021 Nov.
6
Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option.补体抑制剂在年龄相关性黄斑变性中的应用:一种潜在的治疗选择。
J Immunol Res. 2021 Jul 29;2021:9945725. doi: 10.1155/2021/9945725. eCollection 2021.
7
How Structures of Complement Complexes Guide Therapeutic Design.补体复合物结构如何指导治疗设计。
Subcell Biochem. 2021;96:273-295. doi: 10.1007/978-3-030-58971-4_7.
8
Bacterial killing by complement requires direct anchoring of membrane attack complex precursor C5b-7.补体杀菌需要直接锚定膜攻击复合物前体 C5b-7。
PLoS Pathog. 2020 Jun 22;16(6):e1008606. doi: 10.1371/journal.ppat.1008606. eCollection 2020 Jun.
9
Longitudinal proteomics analysis in the immediate microenvironment of islet allografts during progression of rejection.在排斥反应进展过程中胰岛同种异体移植物即刻微环境中的纵向蛋白质组学分析。
J Proteomics. 2020 Jul 15;223:103826. doi: 10.1016/j.jprot.2020.103826. Epub 2020 May 20.
10
The Challenges and Promise of Complement Therapeutics for Ocular Diseases.补体治疗眼部疾病的挑战与前景。
Front Immunol. 2019 May 15;10:1007. doi: 10.3389/fimmu.2019.01007. eCollection 2019.